Roflumilast 500 mcg Tablet Franchise for COPD Treatment in Mumbai Maharashtra

Name: Rofumist Tablet Roflumilast 500 mcg PCD Pharma Franchise
Brand: Rofumist Tablet
Rating: 4.8 (150 reviews)

Rofumist Tablet Effective in Chronic Bronchitis and COPD in Delhi NCR

High-Demand Anti-inflammatory Roflumilast Tablet for Respiratory Care in Chennai Tamil Nadu

Exclusive Rofumist Roflumilast 500 mcg PCD Pharma Franchise in Kolkata West Bengal

Roflumilast 500 mcg Tablet Reliable Respiratory Care Solution in Bangalore Karnataka

Rofumist Tablet PCD Opportunity for COPD and Bronchitis in Hyderabad Telangana

Home/Products /roflumilast-500mcg-tablet

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Stimulant

Urology

Roflumilast 500 mcg Rofumist Tablet Best Price PCD Opportunity

Rofumist Roflumilast Tablet Franchise Manufacturing and Export

Roflumilast 500 mcg High Margin PCD Pharma Deal India

Rofumist Tablet Exclusive Respiratory PCD Monopoly Offer

Roflumilast 500 mcg Rofumist Tablet PCD Franchise Video Overview

Rofumist Tablet Literature PDF & PCD Distribution Opportunity

Rofumist Tablet

Composition : Roflumilast (500mcg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹0/-

Please Contact For Best Price

Rofumist Tablet (Roflumilast 500 mcg) is a selective PDE-4 inhibitor used to reduce inflammation and prevent exacerbations in chronic obstructive pulmonary disease (COPD) and chronic bronchitis. It works by decreasing lung inflammation and improving airflow, making it a vital maintenance therapy for respiratory patients.

Rofumist Tablet is widely prescribed by pulmonologists and respiratory specialists, ensuring consistent market demand. It offers a promising PCD pharma franchise and manufacturing opportunity for companies looking to expand their respiratory segment portfolio. Backed by high prescription value and clinical reliability, Rofumist is ideal for B2B distribution, export, and competitive franchise pricing across India.

About the Product

Common side effects may include headache, nausea, diarrhea, weight loss, or insomnia. Rarely, patients may experience mood changes, anxiety, or allergic reactions. Any severe or persistent side effects should be reported to a healthcare professional promptly.

Rofumist Tablet is indicated for the maintenance treatment of severe COPD associated with chronic bronchitis and a history of frequent exacerbations. It helps in preventing flare-ups, improving airflow, and reducing symptoms like shortness of breath, coughing, and chest tightness.

Take Rofumist Tablet exactly as prescribed by your doctor, usually once daily with or without food. It is not a rescue medication and should not be used to treat sudden breathing problems. Use with caution in patients with liver impairment, depression, or significant weight loss. Regular monitoring of body weight and mental health is advised during prolonged therapy.

Store Rofumist Tablet in a cool, dry place below 25°C, protected from direct sunlight and moisture. Keep out of reach of children and use only within the expiry period mentioned on the packaging.